Clinical Trial Update: Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology [NA]

View source ↗

Summary

Duke University's clinical trial evaluating circulating tumor cells in prostate cancer based on epithelial-mesenchymal transition biology has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer | NA | Status: WITHDRAWN